<DOC>
	<DOCNO>NCT02183038</DOCNO>
	<brief_summary>Study assess efficacy tolerability Meloxicam daily dose 7.5 mg 15 mg compare 1100 mg naproxen sodium symptomatic treatment acute non bacterial pharyngitis pharyngo-tonsillitis , period 5 day .</brief_summary>
	<brief_title>Efficacy Safety Meloxicam vs. Naproxen Sodium Patients With Acute Non Bacterial Pharyngitis Pharyngo-tonsillitis</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Tonsillitis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Male female age 18 year Ambulatory patient Start symptom within previous 24 hour Patients suffer acute non bacterial pharyngitis pharyngotonsillitis diagnostic , follow criterion : spontaneous pharyngeal pain presence great 35 mm 100 mm visual analog scale ( VAS ) Pharyngeal pain presence swallow great 35 mm 100 mm VAS Pharyngeal and/or amygdaline hyperemia Absence purulent plaque Negative test βhaemolytic Streptococcus pharyngeal exudate Therapy NSAID ( NonSteroid AntiInflammatory Drug ) require recommended Patient 's informed consent accordance local law ICH GCP ( International Conference Harmonization Good Clinical Practice ) , inclusion trial Suspicion acute pharyngitis pharyngotonsillitis bacterial origin clinical criterion ; Several impairment patient condition , indicate one follow symptom : Extremely rapid onset clinical picture Very high fever ( &gt; 38.5°C ) Severe pharyngeal pain Cervical adenopathy Intense headache Purulent pharyngeal plaque , evidence peritonsillar abscess phlegmon Known suspect hypersensitivity trial drug NSAIDs Positive test βhaemolytic Streptococcus pharyngeal exudate Therapy antimicrobial agent prior start trial Chronic infection Infectious mononucleosis Active peptic ulcer within past 6 month Pregnancy breast feeding precaution : attention drawn report NSAIDs report decrease efficacy intrauterine device Asthma , nasal polyp , angioneurotic edema urticaria follow administration aspirin NSAIDs Concomitant treatment anticoagulant ( include heparin ) , lithium methotrexate Concomitant administration NSAIDs ( include highdose &gt; 1500 mg day aspirin ) analgesic agent Administration NSAID last three day analgesics 6 hour prior first administration trial drug Present treatment treatment within last two month corticosteroid Historically know impaired renal function ( serum urea &gt; 125 % upper limit normal range ; serum creatinine &gt; 150 % upper limit normal range ) Historically know severe liver injury ( alanine amino transferase ALAT &gt; 2 x upper normal range limit aspartate amino transferase ASAT &gt; 2 x upper normal range limit ) Historically know hematological disorder ( platelet count &lt; 100,000/mm3 , leucocyte count &lt; 3,000/mm3 ) Participation another clinical trial study previous month Previous participation trial Patient unable comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>